Skip to main content
SpringerLink
Log in

HCV treatment recommendations now include prioritising patients

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. American Association for the Study of Liver Disease (AASLD); Infectious Diseases Society of America (IDSA); International Antiviral Society (IAS)-USA

Reference

  • Infectious Diseases Society of America, et al. HCV Treatment Recommendations Now Includes Information on Prioritizing Patients Under Limited Resources. Media Release : 11 Aug 2014. Available from: URL: http://www.hcvguidelines.org

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HCV treatment recommendations now include prioritising patients. PharmacoEcon Outcomes News 710, 4 (2014). https://doi.org/10.1007/s40274-014-1477-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1477-8

Search

Navigation